Relation of serum total cholesterol and other factors to risk of cerebral infarction in Japanese men with hypercholesterolemia: The Kyushu Lipid Intervention Study

Circulation Journal

Volumn 69, Issue 1, 2005, Pages 1-6

  Iwashita, Mikio ^a   Matsushita, Yasuyuki ^b,c   Sasaki, Jun ^d   Arakawa, Kikuo ^e   Kono, Suminori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^e FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral infarction; Diabetes mellitus; High density lipoprotein cholesterol; Hypercholesterolemia; Japanese men

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BODY MASS; BRAIN INFARCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING;

AGED; ALCOHOL DRINKING; ANGINA PECTORIS; BODY MASS INDEX; CEREBRAL INFARCTION; CHOLESTEROL; DIABETES MELLITUS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 12344313935     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.1     Document Type: Article

References (37)

1. Sudlow CLM, Warlow CP for the International Stroke Incidence Collaboration. Comparative studies of the incidence of stroke and its pathological types: Results from an international collaboration. Stroke 1997; 28: 491-499.
2. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
3. Harmsen P, Rosengren A, Tsipogianni A, Wilhelmsen L. Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke 1990; 21: 223-229.
4. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000; 31: 1882-1888.
5. Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality: A 21-year follow up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 1997; 28: 83-87.
6. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke 1998; 29: 1341-1346.
7. Leppälä JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: Association of blood pressure, cholesterol, and antioxidants. Stroke 1999; 30: 2535-2540.
8. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2003; 34: 623-631.
9. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: The Oyabe Study. Stroke 2003; 34: 863-868.
10. Tanaka H, Ueda Y, Hayashi M, Date C, Baba T, Yamashita H, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73.
11. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H. A 15.5-year follow-up study of stroke in a Japanese provincial city: The Shibata Study. Stroke 1997; 28: 45-52.
12. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, et al. Incidence and risk factors for subtype of cerebral infarction in a general population: The Hisayama Study. Stroke 2000; 31: 2616-2622.
13. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD for the MRFIT Research Group. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904-910.
14. Liridenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen city heart study. BMJ 1994; 309: 11-15.
15. Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W, et al. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: Implications of shard risk. Stroke 1994; 25: 814-820.
16. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352: 1801-1807.
17. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JDG, Hunt D, et al. Pravastatin therapy and the risk of stroke. N Engl J Med 2000; 343: 317-326.
18. Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM, et al for the Prospective Pravastatin Pooling (PPP) Project. Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project. Circulation 2001; 103: 387-392.
19. Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, et al. for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Stroke 1998; 29: 1333-1340.
20. The Kyushu Lipid Intervention Group. A coronary primary prevention study of Japanese men: Study design and, implementation and baseline data. J Atheroscler Thromb 1996; 3: 95-104.
21. The Kyushu Lipid Intervention Group. Pravastatin use and risk of coronary events and cerebral infarction in Japanese men with moderate hypercholesterolemia: Kyushu Lipid Intervention Study. J Atheroscler Thromb 2000; 7: 110-121.
22. Sasaki J, Arakawa K, Iwashita M, Matsushita Y, Kono S for the Kyushu Lipid Intervention Study (KLIS) Group. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: The Kyushu Lipid Intervention Study. Circ J 2003; 67: 473-478.
23. Iwashita M, Matsushita Y, Sasaki J, Arakawa K, Kono S for the Kyushu Lipid Intervention Study (KLIS) Group. Relation of serum total cholesterol and other risk factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: The Kyushu Lipid Intervention Study. Circ J 2004; 68: 405-409.
24. Friedewald WJ, Levy RI, Fredrichson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 459-502.
25. The Fukuoka Heart Study Group. Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: A case-control study in Japan. Circ J 2002; 66: 463-468.
26. Piechowski-Jozwiak B, Bogousslavsky J. Cholesterol as a risk factor for stroke: The fugitive? Stroke 2004; 35: 1523-1524.
27. Thrift AG. Cholesterol is associated with stroke, but is not a risk factor. Stroke 2004; 35: 1524-1525.
28. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: Implications fro cardiovascular event reduction. JAMA 1998; 279: 1643-1650.
29. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al for the ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158.
30. Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies of stroke prevention. Arch Intern Med 2003; 163: 669-676.
31. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 2003; 326: 1423-1429.
32. Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Gobbe SM, et al on behalf of the PROSPER study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 2002; 360: 1623-1630.
33. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
34. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al and the J-LIT Study Group. Large scale cohort study of the relationship between serum cholesterol and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66: 1087-1095.
35. Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 2003; 11: 6-11.
36. Steinberg D, Pearson TA, Kuller LH. Alcohol and atherosclerosis. Ann Intern Med 1991; 114: 967-976.
37. Hannuksela ML, Liisanantt MK, Savolainen MJ. Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis. Crit Rev Clin Lab Sci 2002; 39: 225-283.